Skip to playerSkip to main content
  • 3 months ago
CoreWeave shares dropped 5.38% to $102.89 amid investor concerns over valuation, spending, and customer concentration, according to Benzinga. The AI infrastructure firm's stock continues to swing as Wall Street debates the long-term outlook. Shares have surged over 240% since the company's March 2025 IPO, making the stock a point of contention among analysts. Supporters highlight the company’s aggressive expansion, including a $9 billion Core Scientific acquisition and plans for a $6 billion AI data center in Pennsylvania. Barclays raised its price target for CoreWeave to $140 on July 21, citing strong growth prospects. Just days earlier, HSBC initiated coverage with a bearish $32 target and a Reduce rating, highlighting downside risks. CoreWeave closed at $102.89, down 5.38%.

Category

🗞
News
Transcript
00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Corleaf shares dropped 5.38% to $102.89 in investor concerns over valuation,
00:09spending, and customer concentration, according to Benzinga.
00:11The infrastructure firm's stock continues to swing as Wall Street debates the long-term outlook.
00:16Shares have surged over 240% since the company's March 2025 IPO,
00:21making the stock a point of contention among analysts.
00:24Supporters highlight the company's aggressive expansion,
00:26including a $9 billion core scientific acquisition and plans for a $6 billion AI data center in Pennsylvania.
00:32Parkway has raised its price target for Corleaf to $140 on July 21st,
00:36sending strong growth prospects.
00:37Just days earlier, HSBC initiated coverage with a bearish $32 target and a reduced rating,
00:43highlighting downside risks.
00:45Corleaf closed at $102.89, down 5.38%.
00:49For all things money, visit Benzinga.com.
Be the first to comment
Add your comment

Recommended